Target intelligence / Profile preview

RNA, 7SK small nuclear pseudogene 51 (RN7SKP51)

Target
RN7SKP51
Molecular classification
Other, Pseudogene, Non-coding RNA
01

Overview

RN7SK pseudogene 51 (RN7SKP51) is one of the numerous pseudogene variants related to the functional RNA, 7SK small nuclear RNA (RN7SK), which has a well-established role in regulating transcription elongation by RNA polymerase II via sequestration of positive transcription elongation factor b (P-TEFb)[1][2][3]. RN7SKP51 itself is annotated as a pseudogene, meaning it does not produce a functional RNA or protein product and is typically not considered an active molecular target[3]. The functional 7SK RNA, not RN7SKP51, forms the 7SK ribonucleoprotein (RNP) complex that is important for cellular transcriptional regulation[2][3]. Pseudogenes like RN7SKP51 may be transcribed but lack evidence for biological function, disease relevance, or direct pharmacological targeting[3]. There is no evidence in the literature that RN7SKP51 is implicated in disease or is therapeutically targeted, nor is it used as a biomarker or associated with clinical safety concerns. RN7SKP51 is likely annotated by sequence homology alone, reflecting a nonfunctional copy of the parent RN7SK gene. Note: If you intended to ask about the functional form, "RNA, 7SK small nuclear RNA" (RN7SK), that molecule is classified as a long non-coding RNA (lncRNA), involved in transcription regulation, immune cell differentiation, and implicated in cancer and other diseases[1][2][3]. However, "RN7SK pseudogene 51" itself should not be considered a true functional target.

Other names
RN7SKP51RNA, 7SK small nuclear pseudogene 517SK pseudogene 51

Beyond the preview

Go deeper on RNA, 7SK small nuclear pseudogene 51 (RN7SKP51).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 51 (RN7SKP51).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call